Min Pa: Min Pa(max): Activity's type:

Ext	Pa	Pi	Pmax	Activity	Other Results	ID Pa_max
	0.641	0.004	0.641	DNA methylase inhibitor	0.467 0.007 DBMET00691 0.543 0.005 DBMET02351
	0.627	0.014	0.627	MAP kinase 1 inhibitor	0.475 0.064 DBMET00691 0.365 0.127 DBMET02351
	0.618	0.007	0.618	Hypoxia-inducible factor 1 alpha inhibitor	0.263 0.089 DBMET00691 0.431 0.023 DBMET02351
	0.605	0.004	0.632	Alpha 1 adrenoreceptor antagonist	0.092 0.047 DBMET00691 0.632 0.004 DBMET02351	DBMET02351
	0.563	0.005	0.694	Alpha adrenoreceptor antagonist	0.113 0.05 DBMET00691 0.694 0.004 DBMET02351	DBMET02351
	0.549	0.004	0.579	Alpha 1a adrenoreceptor antagonist	0.065 0.054 DBMET00691 0.579 0.004 DBMET02351	DBMET02351
	0.544	0.003	0.586	Alpha 1 adrenoreceptor agonist	0.092 0.019 DBMET00691 0.586 0.003 DBMET02351	DBMET02351
	0.499	0.004	0.672	Alpha 2a adrenoreceptor antagonist	0.151 0.022 DBMET00691 0.672 0.003 DBMET02351	DBMET02351
	0.508	0.039	0.508	15-Lipoxygenase inhibitor
	0.47	0.004	0.596	Alpha 2 adrenoreceptor antagonist	0.149 0.027 DBMET00691 0.596 0.004 DBMET02351	DBMET02351
	0.431	0.027	0.431	Vasodilator, coronary	0.339 0.061 DBMET00691 0.367 0.048 DBMET02351
	0.409	0.008	0.409	DNA methyltransferase I inhibitor	0.386 0.01 DBMET00691 0.297 0.027 DBMET02351
	0.376	0.02	0.532	Cyclic AMP phosphodiesterase inhibitor	0.269 0.055 DBMET00691 0.532 0.005 DBMET02351	DBMET02351
	0.4	0.057	0.4	Thioredoxin glutathione reductase inhibitor
	0.41	0.111	0.41	DNA directed DNA polymerase inhibitor
	0.3	0.005	0.454	Alpha 1d adrenoreceptor antagonist	0.074 0.033 DBMET00691 0.454 0.004 DBMET02351	DBMET02351
	0.409	0.115	0.409	DNA polymerase beta inhibitor
	0.295	0.005	0.587	Alpha adrenoreceptor agonist	0.105 0.026 DBMET00691 0.587 0.003 DBMET02351	DBMET02351
	0.27	0.016	0.499	Antiadrenergic	0.499 0.005 DBMET02351	DBMET02351
	0.267	0.015	0.496	Adrenaline antagonist	0.496 0.005 DBMET02351	DBMET02351
	0.269	0.017	0.392	Toll-Like receptor 9 antagonist	0.225 0.026 DBMET00691 0.392 0.005 DBMET02351	DBMET02351
	0.273	0.026	0.314	Focal adhesion kinase 2 inhibitor	0.314 0.012 DBMET00691 0.28 0.023 DBMET02351	DBMET00691
	0.25	0.01	0.539	Alpha 2c adrenoreceptor antagonist	0.151 0.032 DBMET00691 0.539 0.003 DBMET02351	DBMET02351
	0.246	0.01	0.43	Alpha 1b adrenoreceptor antagonist	0.085 0.042 DBMET00691 0.43 0.005 DBMET02351	DBMET02351
	0.248	0.044	0.462	Proto-oncogene tyrosine-protein kinase Fyn inhibitor	0.462 0.005 DBMET00691 0.413 0.011 DBMET02351	DBMET00691
	0.229	0.036	0.559	RET inhibitor	0.559 0.005 DBMET00691 0.474 0.006 DBMET02351	DBMET00691
	0.209	0.022	0.647	Alpha 2b adrenoreceptor antagonist	0.154 0.037 DBMET00691 0.647 0.003 DBMET02351	DBMET02351
	0.186	0.017	0.287	EphA2 antagonist	0.287 0.004 DBMET00691 0.263 0.005 DBMET02351	DBMET00691
	0.231	0.063	0.44	ErbB-1 antagonist	0.44 0.012 DBMET00691 0.363 0.02 DBMET02351	DBMET00691
	0.174	0.012	0.195	Adenosine A2a receptor antagonist	0.195 0.01 DBMET00691 0.107 0.023 DBMET02351	DBMET00691
	0.174	0.013	0.19	Adenosine A2 receptor antagonist	0.19 0.011 DBMET00691 0.102 0.027 DBMET02351	DBMET00691
	0.275	0.114	0.275	Prostaglandin dehydrogenase inhibitor
	0.213	0.061	0.5	CDC-like kinase 4 inhibitor	0.5 0.006 DBMET00691 0.292 0.034 DBMET02351	DBMET00691
	0.155	0.006	0.332	Alpha 2 adrenoreceptor agonist	0.089 0.019 DBMET00691 0.332 0.003 DBMET02351	DBMET02351
	0.302	0.154	0.302	Transcription factor inhibitor
	0.219	0.075	0.391	EphB2 antagonist	0.386 0.019 DBMET00691 0.391 0.018 DBMET02351	DBMET02351
	0.201	0.057	0.201	Amyloid beta precursor protein antagonist
	0.171	0.032	0.481	Ephrin antagonist	0.481 0.004 DBMET00691 0.289 0.01 DBMET02351	DBMET00691
	0.154	0.024	0.154	Sphingosine 1-phosphate receptor 2 agonist	0.144 0.029 DBMET02351
	0.142	0.012	0.142	Phosphodiesterase V inhibitor	0.14 0.013 DBMET02351
	0.202	0.078	0.592	Clk dual-specificity kinase inhibitor	0.592 0.005 DBMET00691 0.291 0.041 DBMET02351	DBMET00691
	0.167	0.047	0.452	c-Src kinase inhibitor	0.452 0.005 DBMET00691 0.355 0.011 DBMET02351	DBMET00691
	0.182	0.064	0.527	Src kinase inhibitor	0.527 0.005 DBMET00691 0.367 0.016 DBMET02351	DBMET00691
	0.23	0.115	0.23	Streptokinase A inhibitor
	0.13	0.015	0.144	Phosphodiesterase 5A inhibitor	0.144 0.012 DBMET02351	DBMET02351
	0.191	0.079	0.348	I kappa B kinase epsilon inhibitor	0.348 0.005 DBMET00691 0.298 0.015 DBMET02351	DBMET00691
	0.236	0.125	0.377	Caspase 3 stimulant	0.377 0.051 DBMET00691 0.295 0.081 DBMET02351	DBMET00691
	0.172	0.064	0.495	Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor	0.495 0.005 DBMET00691 0.242 0.038 DBMET02351	DBMET00691
	0.277	0.172	0.277	Alpha-glucosidase inhibitor
	0.162	0.058	0.493	Activin receptor-like kinase 2 inhibitor	0.321 0.009 DBMET00691 0.493 0.004 DBMET02351	DBMET02351
	0.199	0.105	0.254	MAP-kinase-activated kinase 5 inhibitor	0.254 0.057 DBMET00691 0.239 0.067 DBMET02351	DBMET00691
	0.172	0.08	0.224	MAP kinase kinase 5 inhibitor	0.224 0.014 DBMET02351	DBMET02351
	0.114	0.028	0.114	Macrophage migration inhibitory factor inhibitor
	0.112	0.028	0.408	Glutamate release inhibitor	0.408 0.002 DBMET00691 0.257 0.004 DBMET02351	DBMET00691
	0.243	0.16	0.243	Beta lactamase inhibitor
	0.139	0.056	0.347	Epidermal growth factor receptor kinase inhibitor	0.347 0.006 DBMET00691 0.228 0.019 DBMET02351	DBMET00691
	0.218	0.138	0.407	Ca2+/calmodulin-dependent kinase II alpha inhibitor	0.407 0.02 DBMET00691 0.393 0.023 DBMET02351	DBMET00691
	0.084	0.006	0.122	Alpha 1L adrenoreceptor antagonist	0.063 0.018 DBMET00691 0.122 0.004 DBMET02351	DBMET02351
	0.108	0.031	0.174	Inducible nitric-oxide synthase inhibitor	0.113 0.028 DBMET00691 0.174 0.011 DBMET02351	DBMET02351
	0.224	0.15	0.552	Vasodilator, peripheral	0.273 0.112 DBMET00691 0.552 0.021 DBMET02351	DBMET02351
	0.104	0.034	0.104	Factor XII inhibitor	0.083 0.06 DBMET00691
	0.133	0.063	0.276	Protein kinase (CK1) delta inhibitor	0.25 0.017 DBMET00691 0.276 0.014 DBMET02351	DBMET02351
	0.096	0.03	0.096	Nav1.8 sodium channel blocker
	0.281	0.216	0.618	Caspase 9 stimulant	0.478 0.069 DBMET00691 0.618 0.034 DBMET02351	DBMET02351
	0.168	0.105	0.451	Antimitotic	0.451 0.017 DBMET00691 0.33 0.037 DBMET02351	DBMET00691
	0.15	0.09	0.407	Protein kinase (CK1) gamma 3 inhibitor	0.407 0.006 DBMET00691 0.181 0.06 DBMET02351	DBMET00691
	0.147	0.088	0.313	Polo-like kinase-3 inhibitor	0.313 0.009 DBMET00691 0.25 0.024 DBMET02351	DBMET00691
	0.103	0.045	0.231	Insulin growth factor antagonist	0.194 0.012 DBMET00691 0.231 0.007 DBMET02351	DBMET02351
	0.098	0.041	0.233	ErbB-4 antagonist	0.233 0.009 DBMET00691 0.184 0.014 DBMET02351	DBMET00691
	0.116	0.06	0.223	Polo-like kinase-4 inhibitor	0.212 0.013 DBMET00691 0.223 0.011 DBMET02351	DBMET02351
	0.098	0.043	0.169	ErbB-3 antagonist	0.135 0.023 DBMET00691 0.169 0.014 DBMET02351	DBMET02351
	0.136	0.081	0.533	Protein kinase (CK1) gamma 1 inhibitor	0.533 0.004 DBMET00691 0.164 0.059 DBMET02351	DBMET00691
	0.093	0.039	0.204	Proto-oncogene tyrosine-protein kinase c-hck inhibitor	0.204 0.005 DBMET00691 0.157 0.012 DBMET02351	DBMET00691
	0.097	0.044	0.223	Insulin like growth factor 1 antagonist	0.184 0.012 DBMET00691 0.223 0.007 DBMET02351	DBMET02351
	0.127	0.075	0.21	Phosphodiesterase inhibitor	0.21 0.032 DBMET02351	DBMET02351
	0.138	0.088	0.3	Heat shock protein 90 antagonist	0.3 0.01 DBMET00691	DBMET00691
	0.081	0.033	0.081	Orexin receptor 1 antagonist
	0.092	0.044	0.164	mTOR complex 2 inhibitor	0.164 0.007 DBMET00691 0.145 0.009 DBMET02351	DBMET00691
	0.077	0.031	0.077	Orexin receptor antagonist
	0.094	0.049	0.317	Epidermal growth factor antagonist	0.317 0.007 DBMET00691 0.191 0.016 DBMET02351	DBMET00691
	0.081	0.04	0.088	MAP kinase 7 inhibitor	0.083 0.034 DBMET00691 0.088 0.023 DBMET02351	DBMET02351
	0.07	0.029	0.27	EphB4 antagonist	0.27 0.004 DBMET00691 0.17 0.009 DBMET02351	DBMET00691
	0.071	0.033	0.154	Adenosine A1 receptor antagonist	0.154 0.015 DBMET00691 0.06 0.039 DBMET02351	DBMET00691
	0.05	0.014	0.104	Phosphoglycerate kinase inhibitor	0.104 0.007 DBMET00691 0.046 0.015 DBMET02351	DBMET00691
	0.119	0.092	0.292	Protein kinase (CK1) inhibitor	0.292 0.019 DBMET00691 0.288 0.019 DBMET02351	DBMET00691
	0.054	0.027	0.054	Nicotinic receptor alpha4 subunit antagonist
	0.086	0.06	0.242	Granulocyte macrophage colony stimulating factor agonist	0.242 0.002 DBMET00691 0.144 0.006 DBMET02351	DBMET00691
	0.11	0.091	0.321	Tubulin antagonist	0.321 0.017 DBMET00691 0.151 0.057 DBMET02351	DBMET00691
	0.108	0.09	0.32	TRKB antagonist	0.32 0.009 DBMET00691 0.275 0.013 DBMET02351	DBMET00691
	0.059	0.042	0.198	Heat shock protein 90 beta antagonist	0.198 0.004 DBMET00691 0.133 0.005 DBMET02351	DBMET00691
	0.17	0.153	0.363	RNA-directed DNA polymerase inhibitor	0.363 0.022 DBMET00691 0.172 0.149 DBMET02351	DBMET00691
	0.145	0.13	0.463	Death-associated protein kinase 3 inhibitor	0.463 0.009 DBMET00691 0.312 0.035 DBMET02351	DBMET00691
	0.058	0.043	0.124	Phosphatidylinositol kinase inhibitor	0.116 0.017 DBMET00691 0.124 0.015 DBMET02351	DBMET02351
	0.051	0.036	0.11	Phosphatidylinositol 3-kinase alpha inhibitor	0.082 0.021 DBMET00691 0.11 0.015 DBMET02351	DBMET02351
	0.021	0.007	0.046	Complement factor D inhibitor	0.02 0.01 DBMET00691 0.046 0.003 DBMET02351	DBMET02351
	0.127	0.112	0.487	CDC-like kinase 2 inhibitor	0.487 0.006 DBMET00691 0.231 0.052 DBMET02351	DBMET00691
	0.138	0.124	0.14	3C-like protease (Human coronavirus) inhibitor	0.14 0.121 DBMET00691	DBMET00691
	0.09	0.077	0.159	Nitric-oxide synthase inhibitor	0.159 0.019 DBMET00691 0.157 0.02 DBMET02351	DBMET00691
	0.07	0.059	0.183	ErbB-2 antagonist	0.183 0.011 DBMET00691 0.117 0.029 DBMET02351	DBMET00691
	0.095	0.084	0.225	Glycogen synthase kinase-3 beta inhibitor	0.179 0.034 DBMET00691 0.225 0.024 DBMET02351	DBMET02351
	0.123	0.113	0.485	Ca2+/calmodulin-dependent kinase II gamma inhibitor	0.485 0.007 DBMET00691 0.286 0.037 DBMET02351	DBMET00691
	0.111	0.102	0.624	Growth factor antagonist	0.624 0.006 DBMET00691 0.367 0.02 DBMET02351	DBMET00691
	0.105	0.097	0.399	Protein-tyrosine kinase Lyn inhibitor	0.399 0.007 DBMET00691 0.236 0.034 DBMET02351	DBMET00691
	0.045	0.037	0.096	CC chemokine 4 receptor antagonist	0.053 0.023 DBMET00691 0.096 0.005 DBMET02351	DBMET02351
	0.058	0.055	0.12	5 Hydroxytryptamine 1A antagonist	0.12 0.026 DBMET02351	DBMET02351
	0.094	0.091	0.438	Protein kinase (CK1) gamma 2 inhibitor	0.438 0.005 DBMET00691 0.156 0.047 DBMET02351	DBMET00691
	0.044	0.042	0.097	Histamine H4 receptor antagonist	0.063 0.016 DBMET00691 0.097 0.005 DBMET02351	DBMET02351
	0.109	0.108	0.389	CDC-like kinase 1 inhibitor	0.389 0.005 DBMET00691 0.154 0.067 DBMET02351	DBMET00691
	0.077	0.077	0.081	Transforming growth factor beta 3 antagonist	0.081 0.06 DBMET02351	DBMET02351
	0.1	0.102	0.424	Lck kinase inhibitor	0.424 0.007 DBMET00691 0.236 0.028 DBMET02351	DBMET00691
	0.078	0.08	0.417	Platelet activating factor beta antagonist	0.417 0.005 DBMET00691 0.199 0.025 DBMET02351	DBMET00691
	0.105	0.108	0.488	Protein kinase (CK1) gamma inhibitor	0.488 0.005 DBMET00691 0.164 0.06 DBMET02351	DBMET00691
	0.088	0.091	0.134	mTOR complex 1 inhibitor	0.134 0.017 DBMET00691 0.111 0.041 DBMET02351	DBMET00691
	0.146	0.15	0.445	Ca2+/calmodulin-dependent kinase I alpha inhibitor	0.445 0.008 DBMET00691 0.264 0.054 DBMET02351	DBMET00691
	0.057	0.061	0.071	Phosphodiesterase 4B inhibitor	0.071 0.043 DBMET02351	DBMET02351
	0.093	0.097	0.137	CDC-like kinase 3 inhibitor	0.137 0.026 DBMET00691 0.096 0.089 DBMET02351	DBMET00691
	0.017	0.022	0.024	Granulocyte colony stimulating factor receptor agonist	0.024 0.005 DBMET00691 0.023 0.005 DBMET02351	DBMET00691
	0.031	0.038	0.04	Adenosine uptake inhibitor	0.035 0.022 DBMET00691 0.04 0.011 DBMET02351	DBMET02351
	0.063	0.072	0.111	Adenosine A3 receptor antagonist	0.111 0.021 DBMET00691	DBMET00691
	0.13	0.139	0.45	Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor	0.45 0.007 DBMET00691 0.265 0.038 DBMET02351	DBMET00691
	0.139	0.148	0.687	Dyrk kinase inhibitor	0.687 0.005 DBMET00691 0.232 0.081 DBMET02351	DBMET00691
	0.076	0.086	0.393	Platelet activating factor alpha antagonist	0.393 0.005 DBMET00691 0.192 0.018 DBMET02351	DBMET00691
	0.03	0.044	0.068	DNA-dependent protein kinase inhibitor	0.068 0.012 DBMET00691 0.062 0.014 DBMET02351	DBMET00691
	0.062	0.077	0.075	Phosphodiesterase VIII inhibitor	0.075 0.043 DBMET00691 0.069 0.055 DBMET02351	DBMET00691
	0.105	0.122	0.556	Tyrosine kinase inhibitor	0.556 0.014 DBMET00691 0.356 0.034 DBMET02351	DBMET00691
	0.131	0.152	0.663	Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor	0.663 0.005 DBMET00691 0.202 0.091 DBMET02351	DBMET00691
	0.1	0.122	0.235	Protein kinase stimulant	0.119 0.094 DBMET00691 0.235 0.03 DBMET02351	DBMET02351
	0.075	0.098	0.157	Phosphodiesterase 7B inhibitor	0.157 0.019 DBMET00691 0.102 0.054 DBMET02351	DBMET00691
	0.065	0.087	0.329	AXL receptor tyrosine kinase inhibitor	0.329 0.005 DBMET00691 0.148 0.018 DBMET02351	DBMET00691
	0.038	0.062	0.225	Phosphatidylinositol 3-kinase delta inhibitor	0.225 0.006 DBMET00691 0.103 0.019 DBMET02351	DBMET00691
	0.079	0.103	0.21	Glycogen synthase kinase-3 inhibitor	0.207 0.03 DBMET00691 0.21 0.029 DBMET02351	DBMET02351
	0.068	0.093	0.077	Phosphodiesterase 11A inhibitor	0.077 0.066 DBMET00691 0.075 0.072 DBMET02351	DBMET00691
	0.068	0.093	0.077	Phosphodiesterase XI inhibitor	0.077 0.066 DBMET00691 0.075 0.072 DBMET02351	DBMET00691
	0.125	0.15	0.438	Ca2+/calmodulin-dependent protein kinase inhibitor	0.438 0.013 DBMET00691 0.343 0.03 DBMET02351	DBMET00691
	0.04	0.067	0.08	Phosphatidylinositol 3-kinase gamma inhibitor	0.08 0.02 DBMET00691 0.073 0.023 DBMET02351	DBMET00691
	0.049	0.079	0.104	5 Hydroxytryptamine 1 antagonist	0.104 0.036 DBMET02351	DBMET02351
	0.035	0.067	0.093	mTOR inhibitor	0.06 0.028 DBMET00691 0.093 0.013 DBMET02351	DBMET02351
	0.096	0.129	0.437	Protein kinase C nu inhibitor	0.437 0.007 DBMET00691 0.265 0.032 DBMET02351	DBMET00691
	0.033	0.067	0.067	Adenosine A2b receptor antagonist	0.067 0.019 DBMET00691	DBMET00691
	0.091	0.128	0.156	Sodium channel blocker	0.156 0.054 DBMET02351	DBMET02351
	0.026	0.068	0.098	Proto-oncogene tyrosine-protein kinase Met inhibitor	0.098 0.01 DBMET00691 0.076 0.018 DBMET02351	DBMET00691
	0.051	0.094	0.094	Protein kinase B beta inhibitor	0.094 0.029 DBMET02351	DBMET02351
	0.053	0.096	0.135	Protein kinase B gamma inhibitor	0.135 0.021 DBMET00691 0.079 0.048 DBMET02351	DBMET00691
	0.034	0.078	0.088	Tyrosine-protein kinase EMT inhibitor	0.088 0.022 DBMET00691 0.054 0.043 DBMET02351	DBMET00691
	0.033	0.077	0.119	Phosphatidylinositol 3-kinase beta inhibitor	0.119 0.01 DBMET00691 0.065 0.022 DBMET02351	DBMET00691
	0.038	0.089	0.08	Alpha 1b adrenoreceptor agonist	0.08 0.008 DBMET02351	DBMET02351
	0.093	0.145	0.347	Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor	0.347 0.008 DBMET00691 0.16 0.066 DBMET02351	DBMET00691
	0.122	0.176	0.442	Ca2+/calmodulin-dependent kinase II beta inhibitor	0.442 0.011 DBMET00691 0.27 0.045 DBMET02351	DBMET00691
	0.044	0.098	0.096	Phosphodiesterase 4D inhibitor	0.079 0.048 DBMET00691 0.096 0.039 DBMET02351	DBMET02351
	0.072	0.128	0.228	Toll-Like receptor 3 antagonist	0.228 0.005 DBMET00691 0.125 0.026 DBMET02351	DBMET00691
	0.184	0.24	0.44	Calcium channel activator	0.336 0.06 DBMET00691 0.44 0.013 DBMET02351	DBMET02351
	0.028	0.086	0.366	Dihydrofolate reductase inhibitor	0.366 0.002 DBMET00691 0.07 0.006 DBMET02351	DBMET00691
	0.079	0.141	0.185	Activin receptor-like kinase 4 inhibitor	0.113 0.061 DBMET00691 0.185 0.017 DBMET02351	DBMET02351
	0.032	0.095	0.222	Purinergic P2X2 antagonist	0.222 0.004 DBMET00691 0.089 0.035 DBMET02351	DBMET00691
	0.048	0.112	0.273	Platelet growth factor antagonist	0.273 0.005 DBMET00691 0.119 0.03 DBMET02351	DBMET00691
	0.064	0.128	0.346	Platelet activating factor antagonist	0.346 0.008 DBMET00691 0.168 0.036 DBMET02351	DBMET00691
	0.085	0.151	0.258	Toll-Like receptor antagonist	0.133 0.069 DBMET00691 0.258 0.013 DBMET02351	DBMET02351
	0.054	0.122	0.202	Aurora-A kinase inhibitor	0.202 0.025 DBMET00691 0.142 0.043 DBMET02351	DBMET00691
	0.044	0.112	0.106	Protein kinase B alpha inhibitor	0.106 0.027 DBMET02351	DBMET02351
	0.086	0.155	0.119	Interleukin 2 antagonist	0.119 0.047 DBMET02351	DBMET02351
	0.034	0.104	0.092	Phosphodiesterase III inhibitor	0.092 0.027 DBMET02351	DBMET02351
	0.038	0.109	0.245	Fibroblast growth factor 2 antagonist	0.245 0.004 DBMET00691 0.162 0.009 DBMET02351	DBMET00691
	0.013	0.085	0.057	Toll-Like receptor 8 agonist	0.057 0.003 DBMET00691	DBMET00691
	0.02	0.093	0.058	Phosphodiesterase 3B inhibitor	0.058 0.02 DBMET02351	DBMET02351
	0.039	0.112	0.167	5 Hydroxytryptamine 2A antagonist	0.167 0.024 DBMET02351	DBMET02351
	0.041	0.114	0.1	ZAP-70 protein tyrosine kinase inhibitor	0.1 0.014 DBMET00691 0.067 0.051 DBMET02351	DBMET00691
	0.078	0.152	0.119	Sodium channel (voltage-gated) blocker	0.119 0.085 DBMET02351	DBMET02351
	0.059	0.133	0.118	Breast cancer-resistant protein inhibitor	0.118 0.04 DBMET00691 0.089 0.067 DBMET02351	DBMET00691
	0.074	0.149	0.489	Vascular endothelial growth factor 3 antagonist	0.489 0.005 DBMET00691 0.308 0.018 DBMET02351	DBMET00691
	0.12	0.196	0.148	Neurotensin receptor agonist	0.148 0.107 DBMET00691 0.139 0.131 DBMET02351	DBMET00691
	0.095	0.17	0.461	Interleukin-1 receptor-associated protein kinase 1 inhibitor	0.461 0.008 DBMET00691 0.227 0.056 DBMET02351	DBMET00691
	0.058	0.138	0.083	Caspase 7 inhibitor	0.083 0.054 DBMET02351	DBMET02351
	0.075	0.158	0.343	Ca2+/calmodulin-dependent kinase II delta inhibitor	0.343 0.011 DBMET00691 0.203 0.045 DBMET02351	DBMET00691
	0.048	0.132	0.246	Fibroblast growth factor 1 antagonist	0.246 0.009 DBMET00691 0.171 0.025 DBMET02351	DBMET00691
	0.09	0.176	0.168	DNA repair enzyme inhibitor	0.168 0.019 DBMET00691 0.147 0.034 DBMET02351	DBMET00691
	0.103	0.188	0.323	Tumour necrosis factor antagonist	0.292 0.019 DBMET00691 0.323 0.014 DBMET02351	DBMET02351
	0.05	0.139	0.311	Tyrosine-protein kinase receptor FLT3 inhibitor	0.276 0.022 DBMET00691 0.311 0.018 DBMET02351	DBMET02351
	0.04	0.128	0.345	TIE-2 antagonist	0.345 0.005 DBMET00691 0.093 0.045 DBMET02351	DBMET00691
	0.04	0.13	0.11	Phosphodiesterase IV inhibitor	0.11 0.038 DBMET02351	DBMET02351
	0.09	0.182	0.341	TRKC antagonist	0.341 0.017 DBMET00691 0.2 0.068 DBMET02351	DBMET00691
	0.04	0.133	0.347	TIE antagonist	0.347 0.006 DBMET00691 0.094 0.046 DBMET02351	DBMET00691
	0.036	0.13	0.103	5 Hydroxytryptamine 3 agonist	0.103 0.014 DBMET02351	DBMET02351
	0.021	0.117	0.053	Protein kinase (CK1) epsilon inhibitor	0.04 0.026 DBMET00691 0.053 0.011 DBMET02351	DBMET02351
	0.042	0.138	0.392	Proto-oncogene tyrosine-protein kinase Kit inhibitor	0.392 0.007 DBMET00691 0.205 0.021 DBMET02351	DBMET00691
	0.067	0.165	0.257	Ribosomal protein S6 kinase inhibitor	0.257 0.019 DBMET00691 0.21 0.033 DBMET02351	DBMET00691
	0.114	0.212	0.192	Tumour necrosis factor alpha release inhibitor	0.192 0.116 DBMET02351	DBMET02351
	0.008	0.111	0.021	O6-alkylguanine-DNA alkyltransferase inhibitor	0.021 0.005 DBMET00691	DBMET00691
	0.052	0.16	0.514	Vascular endothelial growth factor antagonist	0.514 0.008 DBMET00691 0.182 0.044 DBMET02351	DBMET00691
	0.043	0.153	0.517	Vascular endothelial growth factor 2 antagonist	0.517 0.007 DBMET00691 0.176 0.041 DBMET02351	DBMET00691
	0.035	0.148	0.06	Potassium channel (Ca-activated) blocker	0.06 0.041 DBMET00691	DBMET00691
	0.048	0.164	0.194	5 Hydroxytryptamine 2 antagonist	0.194 0.032 DBMET02351	DBMET02351
	0.006	0.126	0.034	Histamine H4 receptor agonist	0.021 0.011 DBMET00691 0.034 0.005 DBMET02351	DBMET02351
	0.046	0.166	0.237	Vascular endothelial growth factor 1 antagonist	0.237 0.019 DBMET00691 0.122 0.053 DBMET02351	DBMET00691
	0.044	0.169	0.22	Check point kinase 2 inhibitor	0.22 0.013 DBMET00691 0.157 0.029 DBMET02351	DBMET00691
	0.067	0.196	0.302	Folate antagonist	0.302 0.004 DBMET00691 0.107 0.053 DBMET02351	DBMET00691
	0.084	0.217	0.193	Heat shock protein 90 alpha antagonist	0.193 0.054 DBMET00691	DBMET00691
	0.013	0.147	0.104	Beta tubulin antagonist	0.104 0.021 DBMET00691	DBMET00691
	0.025	0.165	0.063	5 Hydroxytryptamine 3A antagonist	0.063 0.051 DBMET02351	DBMET02351
	0.043	0.185	0.141	Hepatocyte growth factor antagonist	0.141 0.025 DBMET00691 0.12 0.036 DBMET02351	DBMET00691
	0.045	0.19	0.278	Aurora-B kinase inhibitor	0.278 0.017 DBMET00691 0.186 0.035 DBMET02351	DBMET00691
	0.007	0.153	0.033	Cyclin E2 inhibitor	0.033 0.016 DBMET02351	DBMET02351
	0.023	0.17	0.111	CDC7 inhibitor	0.111 0.019 DBMET00691 0.077 0.037 DBMET02351	DBMET00691
	0.084	0.233	0.368	MAP kinase kinase 2 inhibitor	0.368 0.017 DBMET00691 0.31 0.032 DBMET02351	DBMET00691
	0.108	0.258	0.291	DNA damaging	0.291 0.061 DBMET00691 0.178 0.136 DBMET02351	DBMET00691
	0.022	0.173	0.051	Potassium channel small-conductance Ca-activated blocker	0.051 0.024 DBMET00691 0.051 0.023 DBMET02351	DBMET02351
	0.142	0.293	0.207	Apoptosis antagonist	0.207 0.17 DBMET02351	DBMET02351
	0.028	0.183	0.097	Leucine-rich repeat kinase 2 inhibitor	0.097 0.044 DBMET00691 0.076 0.061 DBMET02351	DBMET00691
	0.05	0.205	0.144	MAP kinase 13 inhibitor	0.144 0.039 DBMET00691 0.136 0.043 DBMET02351	DBMET00691
	0.033	0.19	0.14	ALK inhibitor	0.14 0.022 DBMET00691 0.122 0.029 DBMET02351	DBMET00691
	0.038	0.196	0.221	Granulocyte macrophage colony stimulating factor antagonist	0.221 0.017 DBMET00691 0.128 0.048 DBMET02351	DBMET00691
	0.017	0.176	0.035	ATR kinase inhibitor	0.035 0.018 DBMET02351	DBMET02351
	0.021	0.185	0.08	Histamine agonist	0.079 0.014 DBMET00691 0.08 0.014 DBMET02351	DBMET02351
	0.018	0.187	0.059	Phosphodiesterase 4C inhibitor	0.059 0.036 DBMET02351	DBMET02351
	0.065	0.234	0.372	Aryl hydrocarbon receptor agonist	0.372 0.043 DBMET00691	DBMET00691
	0.048	0.219	0.182	Protein kinase C zeta inhibitor	0.182 0.014 DBMET00691 0.14 0.023 DBMET02351	DBMET00691
	0.02	0.194	0.094	Macrophage colony-stimulating factor 1 receptor antagonist	0.094 0.031 DBMET00691 0.067 0.057 DBMET02351	DBMET00691
	0.02	0.194	0.06	H+/K+-transporting ATPase inhibitor	0.06 0.025 DBMET00691	DBMET00691
	0.03	0.203	0.069	Polo-like kinase-2 inhibitor	0.069 0.054 DBMET02351	DBMET02351
	0.019	0.194	0.105	Cyclin A2 inhibitor	0.105 0.023 DBMET00691 0.101 0.024 DBMET02351	DBMET00691
	0.05	0.227	0.211	Beta amyloid protein antagonist	0.203 0.016 DBMET00691 0.211 0.014 DBMET02351	DBMET02351
	0.016	0.195	0.091	Toll-Like receptor 8 antagonist	0.091 0.012 DBMET02351	DBMET02351
	0.033	0.214	0.088	Adrenaline agonist	0.088 0.048 DBMET02351	DBMET02351
	0.034	0.215	0.134	5 Hydroxytryptamine antagonist	0.134 0.057 DBMET02351	DBMET02351
	0.023	0.205	0.108	Toll-Like receptor 7 antagonist	0.108 0.017 DBMET02351	DBMET02351
	0.049	0.233	0.189	Tyrosine-protein kinase receptor antagonist	0.189 0.045 DBMET00691 0.183 0.048 DBMET02351	DBMET00691
	0.024	0.213	0.063	Epithelial sodium channel blocker	0.063 0.025 DBMET00691 0.063 0.025 DBMET02351	DBMET02351
	0.108	0.298	0.137	Heat shock protein 70 antagonist	0.137 0.085 DBMET00691 0.134 0.101 DBMET02351	DBMET00691
	0.014	0.205	0.056	Bruton tyrosine kinase inhibitor	0.056 0.039 DBMET00691	DBMET00691
	0.046	0.237	0.141	MAP kinase 12 inhibitor	0.141 0.048 DBMET00691 0.124 0.065 DBMET02351	DBMET00691
	0.026	0.218	0.194	Cyclin-dependent kinase 1 inhibitor	0.194 0.027 DBMET00691 0.106 0.062 DBMET02351	DBMET00691
	0.031	0.223	0.09	Focal adhesion kinase 1 inhibitor	0.09 0.039 DBMET00691 0.075 0.055 DBMET02351	DBMET00691
	0.034	0.228	0.185	Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor	0.185 0.032 DBMET00691 0.116 0.072 DBMET02351	DBMET00691
	0.034	0.228	0.184	Abl kinase inhibitor	0.184 0.032 DBMET00691 0.116 0.072 DBMET02351	DBMET00691
	0.017	0.212	0.094	Cyclin A inhibitor	0.094 0.025 DBMET00691 0.088 0.027 DBMET02351	DBMET00691
	0.026	0.221	0.202	Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor	0.202 0.018 DBMET00691	DBMET00691
	0.013	0.211	0.107	Raf kinase B inhibitor	0.107 0.021 DBMET00691	DBMET00691
	0.011	0.21	0.073	Fructose-1,6-bisphosphatase inhibitor	0.073 0.011 DBMET00691	DBMET00691
	0.023	0.224	0.108	Rho-associated kinase I inhibitor	0.102 0.03 DBMET00691 0.108 0.027 DBMET02351	DBMET02351
	0.013	0.217	0.074	Alpha tubulin antagonist	0.074 0.022 DBMET00691	DBMET00691
	0.042	0.25	0.36	Proto-oncogene tyrosine-protein kinase Yes inhibitor	0.36 0.01 DBMET00691 0.116 0.085 DBMET02351	DBMET00691
	0.031	0.243	0.173	Cyclin-dependent kinase 2 inhibitor	0.173 0.03 DBMET00691 0.107 0.063 DBMET02351	DBMET00691
	0.036	0.251	0.257	Cyclin-dependent kinase 9 inhibitor	0.257 0.013 DBMET00691 0.192 0.024 DBMET02351	DBMET00691
	0.009	0.225	0.074	5 Hydroxytryptamine 2 agonist	0.074 0.018 DBMET02351	DBMET02351
	0.015	0.235	0.127	Raf kinase inhibitor	0.127 0.023 DBMET00691	DBMET00691
	0.064	0.286	0.198	Cyclin-dependent kinase 8 inhibitor	0.198 0.037 DBMET00691 0.162 0.068 DBMET02351	DBMET00691
	0.037	0.26	0.199	Insulin receptor antagonist	0.199 0.015 DBMET00691 0.115 0.046 DBMET02351	DBMET00691
	0.03	0.254	0.133	CDK2/cyclin A inhibitor	0.133 0.034 DBMET00691 0.082 0.077 DBMET02351	DBMET00691
	0.012	0.239	0.092	5 Hydroxytryptamine agonist	0.092 0.036 DBMET02351	DBMET02351
	0.021	0.251	0.112	Interleukin-1 receptor-associated protein kinase 4 inhibitor	0.112 0.037 DBMET00691 0.097 0.048 DBMET02351	DBMET00691
	0.016	0.247	0.13	Fibroblast growth factor 3 antagonist	0.13 0.02 DBMET00691 0.099 0.033 DBMET02351	DBMET00691
	0.017	0.251	0.072	Protein kinase C eta inhibitor	0.072 0.028 DBMET02351	DBMET02351
	0.006	0.245	0.079	5 Hydroxytryptamine 2C agonist	0.079 0.011 DBMET02351	DBMET02351
	0.002	0.241	0.008	Phosphoribosylglycinamide formyltransferase inhibitor	0.008 0.005 DBMET00691	DBMET00691
	0.03	0.272	0.084	MAP-kinase-activated kinase inhibitor	0.084 0.056 DBMET02351	DBMET02351
	0.024	0.271	0.119	CDK/cyclin complex inhibitor	0.119 0.041 DBMET00691 0.081 0.067 DBMET02351	DBMET00691
	0.006	0.253	0.028	Potassium channel small-conductance Ca-activated activator	0.028 0.026 DBMET02351	DBMET02351
	0.048	0.295	0.143	Amyloid beta aggregation inhibitor	0.143 0.114 DBMET00691	DBMET00691
	0.051	0.301	0.324	LIM domain kinase 1 inhibitor	0.324 0.016 DBMET00691 0.142 0.107 DBMET02351	DBMET00691
	0.013	0.264	0.045	Tryptophan 5 hydroxylase inhibitor	0.045 0.008 DBMET00691	DBMET00691
	0.06	0.311	0.156	Hexokinase inhibitor	0.156 0.072 DBMET00691	DBMET00691
	0.018	0.27	0.062	CDK2/cyclin E2 inhibitor	0.062 0.059 DBMET02351	DBMET02351
	0.036	0.288	0.085	Transcription factor RelA inhibitor	0.085 0.013 DBMET00691	DBMET00691
	0.025	0.279	0.076	Phosphodiesterase 3A inhibitor	0.076 0.062 DBMET00691	DBMET00691
	0.01	0.265	0.097	CDK1/cyclin B inhibitor	0.097 0.026 DBMET00691	DBMET00691
	0.03	0.287	0.212	Glycogen synthase kinase-3 alpha inhibitor	0.212 0.038 DBMET00691 0.115 0.088 DBMET02351	DBMET00691
	0.094	0.353	0.23	Glyceraldehyde-3-phosphate dehydrogenase inhibitor	0.23 0.052 DBMET00691 0.167 0.114 DBMET02351	DBMET00691
	0.023	0.283	0.214	Cyclin-dependent kinase 5 inhibitor	0.214 0.02 DBMET00691 0.108 0.068 DBMET02351	DBMET00691
	0.034	0.295	0.176	Cyclin-dependent kinase inhibitor	0.176 0.045 DBMET00691 0.119 0.074 DBMET02351	DBMET00691
	0.014	0.275	0.052	Protein kinase C theta inhibitor	0.052 0.05 DBMET02351	DBMET02351
	0.035	0.298	0.109	Mucolytic	0.109 0.066 DBMET00691	DBMET00691
	0.015	0.283	0.048	Transforming growth factor beta 1 antagonist	0.048 0.036 DBMET00691	DBMET00691
	0.058	0.326	0.232	Interleukin agonist	0.232 0.093 DBMET02351	DBMET02351
	0.011	0.279	0.066	Fibroblast growth factor 4 antagonist	0.066 0.031 DBMET00691	DBMET00691
	0.022	0.291	0.071	MAP-kinase-activated kinase 2 inhibitor	0.071 0.056 DBMET02351	DBMET02351
	0.021	0.29	0.171	Protein kinase (CK2) alpha inhibitor	0.171 0.032 DBMET00691 0.113 0.067 DBMET02351	DBMET00691
	0.039	0.311	0.123	MAP kinase kinase 7 inhibitor	0.123 0.004 DBMET00691 0.097 0.016 DBMET02351	DBMET00691
	0.061	0.335	0.326	Platelet aggregation inhibitor	0.326 0.03 DBMET00691 0.234 0.059 DBMET02351	DBMET00691
	0.062	0.347	0.15	Hemostatic	0.15 0.067 DBMET02351	DBMET02351
	0.036	0.322	0.085	Falcipain 2 inhibitor	0.085 0.064 DBMET00691	DBMET00691
	0.036	0.325	0.086	Falcipain inhibitor	0.086 0.066 DBMET00691	DBMET00691
	0.031	0.32	0.107	5 Hydroxytryptamine 2B antagonist	0.107 0.075 DBMET02351	DBMET02351
	0.014	0.303	0.07	Syk tyrosine kinase inhibitor	0.07 0.049 DBMET00691 0.064 0.055 DBMET02351	DBMET00691
	0.014	0.307	0.088	Mannitol-1-phosphate 5-dehydrogenase inhibitor	0.088 0.017 DBMET00691	DBMET00691
	0.059	0.354	0.217	GABA C receptor rho-2 antagonist	0.217 0.021 DBMET00691 0.171 0.05 DBMET02351	DBMET00691
	0.04	0.335	0.181	Interleukin 5 antagonist	0.181 0.007 DBMET00691	DBMET00691
	0.012	0.308	0.063	Cyclin A1 inhibitor	0.057 0.044 DBMET00691 0.063 0.032 DBMET02351	DBMET02351
	0.01	0.308	0.067	Phosphodiesterase VII inhibitor	0.067 0.038 DBMET00691	DBMET00691
	0.03	0.329	0.113	TRKA antagonist	0.113 0.073 DBMET00691 0.101 0.088 DBMET02351	DBMET00691
	0.036	0.335	0.116	NADH dehydrogenase inhibitor	0.116 0.031 DBMET00691 0.08 0.075 DBMET02351	DBMET00691
	0.033	0.334	0.18	Cyclin-dependent kinase 7 inhibitor	0.18 0.042 DBMET00691 0.134 0.073 DBMET02351	DBMET00691
	0.024	0.327	0.125	Protein kinase C delta inhibitor	0.125 0.034 DBMET02351	DBMET02351
	0.047	0.356	0.495	Interleukin 4 antagonist	0.495 0.004 DBMET00691	DBMET00691
	0.009	0.334	0.087	CDK9/cyclin T1 inhibitor	0.087 0.023 DBMET00691	DBMET00691
	0.02	0.345	0.103	Pim-3 kinase inhibitor	0.096 0.049 DBMET00691 0.103 0.043 DBMET02351	DBMET02351
	0.005	0.332	0.124	Dihydropteroate synthase inhibitor	0.124 0.004 DBMET00691	DBMET00691
	0.016	0.343	0.08	Rho-associated kinase inhibitor	0.08 0.046 DBMET00691	DBMET00691
	0.025	0.355	0.151	Protein kinase C mu inhibitor	0.104 0.053 DBMET00691 0.151 0.026 DBMET02351	DBMET02351
	0.083	0.417	0.188	Nootropic	0.188 0.175 DBMET02351	DBMET02351
	0.046	0.382	0.101	Interleukin 12 antagonist	0.101 0.052 DBMET00691	DBMET00691
	0.023	0.359	0.117	Alkylator	0.117 0.071 DBMET00691	DBMET00691
	0.06	0.398	0.147	CF transmembrane conductance regulator agonist	0.147 0.082 DBMET00691	DBMET00691
	0.003	0.342	0.026	Fructose-1,6-bisphosphatase 1 inhibitor	0.026 0.011 DBMET00691	DBMET00691
	0.07	0.414	0.601	Angiogenesis inhibitor	0.601 0.016 DBMET00691 0.261 0.115 DBMET02351	DBMET00691
	0.005	0.352	0.062	CDK2/cyclin E inhibitor	0.062 0.041 DBMET00691	DBMET00691
	0.003	0.352	0.017	5 Lipoxygenase activating protein inhibitor	0.017 0.006 DBMET00691	DBMET00691
	0.026	0.38	0.111	Aminoacyl-tRNA synthetase inhibitor	0.111 0.035 DBMET00691	DBMET00691
	0.012	0.368	0.113	Protein kinase (CK2) inhibitor	0.113 0.053 DBMET00691	DBMET00691
	0.008	0.366	0.086	Growth hormone secretagogue receptor antagonist	0.086 0.009 DBMET00691	DBMET00691
	0.014	0.372	0.069	Cytokine production stimulant	0.069 0.008 DBMET00691	DBMET00691
	0.007	0.367	0.018	Tryptophan hydroxylase 1 inhibitor	0.018 0.01 DBMET00691	DBMET00691
	0.065	0.429	0.256	Superoxide dismutase inhibitor	0.218 0.1 DBMET00691 0.256 0.071 DBMET02351	DBMET02351
	0.022	0.387	0.19	Myeloperoxidase inhibitor	0.19 0.006 DBMET00691 0.088 0.053 DBMET02351	DBMET00691
	0.005	0.378	0.098	Raf kinase C inhibitor	0.098 0.026 DBMET00691	DBMET00691
	0.079	0.453	0.374	Toll-Like receptor 7 agonist	0.374 0.071 DBMET00691 0.253 0.145 DBMET02351	DBMET00691
	0.078	0.453	0.426	Toll-Like receptor agonist	0.426 0.051 DBMET00691 0.259 0.141 DBMET02351	DBMET00691
	0.01	0.385	0.075	Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor	0.075 0.055 DBMET02351	DBMET02351
	0.008	0.386	0.058	Cyclin B inhibitor	0.058 0.034 DBMET00691	DBMET00691
	0.076	0.454	0.424	Immunomodulator	0.424 0.038 DBMET00691	DBMET00691
	0.015	0.398	0.067	Rho-associated kinase II inhibitor	0.067 0.06 DBMET00691	DBMET00691
	0.042	0.426	0.207	Aldehyde oxidase inhibitor	0.207 0.101 DBMET00691	DBMET00691
	0.014	0.401	0.043	3-Hydroxyanthranilate 3,4-dioxygenase inhibitor	0.043 0.026 DBMET00691	DBMET00691
	0.093	0.483	0.273	Nitric-oxide synthase stimulant	0.273 0.02 DBMET00691 0.192 0.104 DBMET02351	DBMET00691
	0.041	0.431	0.104	T cell inhibitor	0.104 0.021 DBMET00691	DBMET00691
	0.046	0.439	0.154	Succinate dehydrogenase inhibitor	0.154 0.106 DBMET00691	DBMET00691
	0.015	0.409	0.109	S-adenosyl-L-methionine decarboxylase inhibitor	0.109 0.009 DBMET00691	DBMET00691
	0.028	0.422	0.104	Phosphodiesterase I inhibitor	0.104 0.04 DBMET00691	DBMET00691
	0.009	0.407	0.06	5 Hydroxytryptamine 2A agonist	0.06 0.047 DBMET02351	DBMET02351
	0.025	0.423	0.131	GABA C receptor rho-1 antagonist	0.131 0.032 DBMET00691 0.116 0.043 DBMET02351	DBMET00691
	0.003	0.405	0.033	Endothelial nitric-oxide synthase inhibitor	0.033 0.019 DBMET00691	DBMET00691
	0.003	0.406	0.066	Antimetabolite	0.066 0.023 DBMET00691	DBMET00691
	0.019	0.422	0.13	Polo-like kinase-1 inhibitor	0.13 0.025 DBMET00691 0.09 0.062 DBMET02351	DBMET00691
	0.013	0.419	0.147	Protein kinase A inhibitor	0.147 0.025 DBMET00691 0.082 0.058 DBMET02351	DBMET00691
	0.081	0.491	0.377	GABA C receptor rho-3 antagonist	0.377 0.072 DBMET00691 0.277 0.132 DBMET02351	DBMET00691
	0.028	0.438	0.107	Electrolyte absorption antagonist	0.107 0.049 DBMET00691	DBMET00691
	0.007	0.418	0.088	Xanthine dehydrogenase inhibitor	0.088 0.02 DBMET00691	DBMET00691
	0.035	0.446	0.184	MAP3K9 inhibitor	0.184 0.024 DBMET00691 0.119 0.116 DBMET02351	DBMET00691
	0.018	0.435	0.055	Factor IXa inhibitor	0.055 0.031 DBMET00691	DBMET00691
	0.017	0.436	0.051	Alpha 1L adrenoreceptor agonist	0.051 0.015 DBMET02351	DBMET02351
	0.009	0.43	0.054	Adenosine deaminase inhibitor	0.054 0.027 DBMET00691	DBMET00691
	0.036	0.458	0.18	Antiamyloidogenic	0.171 0.122 DBMET00691 0.18 0.114 DBMET02351	DBMET02351
	0.016	0.444	0.092	MAP kinase 8 inhibitor	0.092 0.071 DBMET00691	DBMET00691
	0.011	0.439	0.068	AICAR transformylase inhibitor	0.068 0.01 DBMET00691	DBMET00691
	0.008	0.444	0.065	Cyclin B1 inhibitor	0.065 0.037 DBMET00691	DBMET00691
	0.019	0.456	0.122	MAP kinase 9 inhibitor	0.122 0.048 DBMET00691	DBMET00691
	0.029	0.468	0.096	DOPA decarboxylase inhibitor	0.096 0.085 DBMET00691	DBMET00691
	0.044	0.483	0.305	DNA synthesis inhibitor	0.305 0.042 DBMET00691 0.2 0.123 DBMET02351	DBMET00691
	0.022	0.464	0.072	GABA B receptor agonist	0.072 0.064 DBMET00691	DBMET00691
	0.007	0.453	0.054	Cyclin B2 inhibitor	0.054 0.041 DBMET00691	DBMET00691
	0.037	0.489	0.092	Adenylate kinase inhibitor	0.092 0.083 DBMET00691	DBMET00691
	0.08	0.533	0.258	Apoptosis agonist	0.258 0.205 DBMET00691	DBMET00691
	0.017	0.482	0.177	Protein kinase C gamma inhibitor	0.177 0.02 DBMET00691 0.142 0.036 DBMET02351	DBMET00691
	0.035	0.501	0.14	Aurora-C kinase inhibitor	0.14 0.065 DBMET00691	DBMET00691
	0.044	0.511	0.154	Ca2+/calmodulin-dependent protein kinase kinase B inhibitor	0.154 0.065 DBMET00691	DBMET00691
	0.018	0.488	0.086	GABA C receptor agonist	0.086 0.084 DBMET00691	DBMET00691
	0.058	0.529	0.163	MAP kinase kinase 4 inhibitor	0.163 0.04 DBMET00691	DBMET00691
	0.011	0.489	0.038	Glutamate (mGluR group III) agonist	0.038 0.036 DBMET00691	DBMET00691
	0.013	0.494	0.154	MAP kinase kinase inhibitor	0.154 0.049 DBMET00691	DBMET00691
	0.018	0.504	0.115	5 Hydroxytryptamine 3A agonist	0.115 0.06 DBMET02351	DBMET02351
	0.01	0.507	0.076	Secretase beta inhibitor	0.076 0.041 DBMET00691	DBMET00691
	0.012	0.509	0.127	Potassium channel (ATP-sensitive) blocker	0.127 0.007 DBMET00691	DBMET00691
	0.012	0.54	0.152	Interferon agonist	0.152 0.01 DBMET00691	DBMET00691
	0.06	0.59	0.255	5 Hydroxytryptamine release stimulant	0.224 0.103 DBMET00691 0.255 0.087 DBMET02351	DBMET02351
	0.006	0.537	0.039	Histamine H2 receptor agonist	0.039 0.035 DBMET00691	DBMET00691
	0.103	0.64	0.202	Ca2+/calmodulin-dependent kinase IV inhibitor	0.202 0.16 DBMET02351	DBMET02351
	0.032	0.572	0.225	Transcription factor NF kappa B inhibitor	0.225 0.147 DBMET00691	DBMET00691
	0.017	0.556	0.112	I kappa B kinase 1 inhibitor	0.112 0.017 DBMET00691	DBMET00691
	0.097	0.638	0.248	Calcium channel L-type activator	0.248 0.207 DBMET00691 0.244 0.212 DBMET02351	DBMET00691
	0.012	0.554	0.108	MAP kinase kinase 1 inhibitor	0.108 0.047 DBMET00691	DBMET00691
	0.021	0.565	0.061	Immunoglobulin Fc receptor antagonist	0.061 0.023 DBMET00691	DBMET00691
	0.006	0.553	0.04	5 Hydroxytryptamine 2B agonist	0.04 0.025 DBMET02351	DBMET02351
	0.026	0.584	0.229	Peroxidase inhibitor	0.229 0.052 DBMET00691	DBMET00691
	0.004	0.564	0.076	Thymidylate synthase inhibitor	0.076 0.009 DBMET00691	DBMET00691
	0.008	0.568	0.075	CDK1/cyclin B1 inhibitor	0.075 0.043 DBMET00691	DBMET00691
	0.001	0.571	0.018	Cyclin T1 inhibitor	0.018 0.012 DBMET00691	DBMET00691
	0.01	0.582	0.072	Cyclin D1 inhibitor	0.072 0.026 DBMET00691	DBMET00691
	0.007	0.583	0.097	Phenylalanine 4-hydroxylase inhibitor	0.097 0.027 DBMET00691	DBMET00691
	0.027	0.604	0.082	D-Ala-D-Ala ligase inhibitor	0.082 0.064 DBMET00691	DBMET00691
	0.01	0.589	0.11	I kappa B kinase inhibitor	0.11 0.031 DBMET00691	DBMET00691
	0.012	0.592	0.113	Histamine N-methyltransferase inhibitor	0.113 0.035 DBMET00691	DBMET00691
	0.096	0.676	0.295	Ca2+/calmodulin-dependent protein kinase kinase A inhibitor	0.295 0.22 DBMET00691	DBMET00691
	0.012	0.594	0.107	GABA C receptor antagonist	0.107 0.068 DBMET00691 0.093 0.09 DBMET02351	DBMET00691
	0.013	0.597	0.059	Phosphodiesterase 1A inhibitor	0.059 0.043 DBMET00691	DBMET00691
	0.011	0.596	0.104	Interferon inducer	0.104 0.011 DBMET00691	DBMET00691
	0.037	0.634	0.17	MAP kinase 3 inhibitor	0.17 0.043 DBMET00691	DBMET00691
	0.005	0.608	0.066	Protein kinase C alpha inhibitor	0.066 0.049 DBMET02351	DBMET02351
	0.076	0.68	0.2	5 Hydroxytryptamine uptake stimulant	0.2 0.152 DBMET00691	DBMET00691
	0.031	0.638	0.209	Neurotrophic factor enhancer	0.209 0.068 DBMET00691	DBMET00691
	0.003	0.637	0.036	CDK5/p25 inhibitor	0.036 0.035 DBMET00691	DBMET00691
	0.042	0.678	0.204	Growth factor agonist	0.204 0.059 DBMET00691	DBMET00691
	0.014	0.655	0.085	Xanthine oxidase inhibitor	0.085 0.08 DBMET00691	DBMET00691
	0.013	0.655	0.084	Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor	0.084 0.058 DBMET00691	DBMET00691
	0.019	0.669	0.124	Carbonic anhydrase XV inhibitor	0.124 0.043 DBMET00691	DBMET00691
	0.046	0.701	0.471	5 Hydroxytryptamine release inhibitor	0.471 0.043 DBMET00691	DBMET00691
	0.011	0.677	0.139	Nav1.6 sodium channel blocker	0.139 0.067 DBMET00691	DBMET00691
	0.021	0.694	0.177	ATPase inhibitor	0.177 0.061 DBMET00691	DBMET00691
	0.016	0.727	0.223	Cytokine production inhibitor	0.223 0.03 DBMET00691	DBMET00691
	0.028	0.742	0.386	Histamine release inhibitor	0.386 0.083 DBMET00691	DBMET00691
	0.014	0.728	0.138	Antipruritic	0.138 0.109 DBMET00691	DBMET00691
	0.014	0.734	0.093	HIV-1 integrase (Overall Integration) inhibitor	0.093 0.062 DBMET00691	DBMET00691
	0.009	0.74	0.155	Immunostimulant	0.155 0.15 DBMET00691	DBMET00691
	0.011	0.765	0.102	Interleukin 8 antagonist	0.102 0.092 DBMET00691	DBMET00691
Ext	Pa	Pi	Pmax	Activity	Other Results	ID Pa_max